# PBH — Prestige Consumer Healthcare Inc. · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** PBH  
**Sources:** 26  
**Published:** 2026-08-06  
**Canonical:** https://app.k3vl4r.com/research/deep-research-pbh-prestige-consumer-healthcare-inc-catalysts-narrative-1642

---

# Prestige Consumer Healthcare Inc. (PBH) — Research Summary as of August 6, 2026

## Key Recent Catalysts (Last ~1–3 Months)

### Q1 Fiscal 2027 Earnings (Reported August 6, 2026)
On August 6, 2026, Prestige Consumer Healthcare reported its fiscal Q1 2027 results (quarter ended June 30, 2026) [[1]](https://markets.businessinsider.com/news/stocks/prestige-consumer-healthcare-inc-reports-fiscal-2027-first-quarter-results-1036418779?op=1). The results were notably strong: PBH delivered earnings and revenue surprises of **+10.11% and +6.18%**, respectively [[2]](https://www.zacks.com/stock/news/2969555/prestige-consumer-healthcare-pbh-q1-earnings-and-revenues-surpass-estimates)[[3]](https://www.zacks.com/stock/news/2969555/prestige-consumer-healthcare-pbh-q1-earnings-and-revenues-surpass-estimates). This beat appears to reflect the momentum from organic growth and acquisition integration that had been building.

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-pbh-prestige-consumer-healthcare-inc-catalysts-narrative-1642 (free to sign up)._